DVLA

Darya-Varia Laboratoria Tbk

DVLA.JK darya-varia.com
1,590.00
-5.00 (-0.31%)
IDR · JK
52-week range
1,391.82
1,626.99
Trading at 84% of the 52-week range
Market Cap
1.79T
P/E Ratio
13.07
Forward P/E
0.00
Book Value
1,339.36
Div. Yield
4.00%
% Institutions
0.012%
% Insiders
92.12%

1 Year

+5.8%

3 Year

-2.3%

10 Year

+65.7%
Description

PT Darya-Varia Laboratoria Tbk manufactures and trades pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Consumer Health Products, Prescription Drugs, Export & Toll Manufacturing, and Services. The company offers consumer health products, including skin nutrition products under the Natur-E brand; respiratory products under the Decolgen, ALLERIN EXPECTORANT, Decolsin, NEOZEP, STOP COLD, SILEX, and HERBABLEND brands for nasal congestion, cough, and breathing issues caused by allergy; multivitamins under the Enervon-C, Enervon Active, Enervon Gold, and Supertin brands; vitamin C under the Vicee brand; supplement for kids with Zinc and vitamin C under the Imunped brand; Biogesic for various types of pain; Diatabs, a anti diarrhea product; and New Enzyplex to prevent indigestion. It also provides prescription products for various therapeutic areas, including cardiology, analgesics, gastro-hepatology, dermamedic, somatic, cough and cold, antibiotic, women healthcare, antiparasit, vitamin and food supplements, anti fungal, plastic surgery, general surgery, burn, trauma wound, aesthetic medicine, somatik, ear healthcare, and central nerve systems. In addition, the company offers toll manufacturing services for soft gelatin capsules, as well as sterile injections and low volume solid products. It also exports its products. The company was founded in 1976 and is headquartered in Jakarta, Indonesia. PT Darya-Varia Laboratoria Tbk operates as a subsidiary of Blue Sphere Singapore Pte. Ltd.

Company Information

Company Name
Darya-Varia Laboratoria Tbk
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
JK
ISIN: ID1000117203
Currency: IDR
Full Time Employees: 1,357
Phone: 62 21 227 68000
Fiscal Year End: December
IPO Date: Nov 11, 1994
Description:

PT Darya-Varia Laboratoria Tbk manufactures and trades pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Consumer Health Products, Prescription Drugs, Export & Toll Manufacturing, and Services. The company offers consumer health products, including skin nutrition products under the Natur-E brand; respiratory products under the Decolgen, ALLERIN EXPECTORANT, Decolsin, NEOZEP, STOP COLD, SILEX, and HERBABLEND brands for nasal congestion, cough, and breathing issues caused by allergy; multivitamins under the Enervon-C, Enervon Active, Enervon Gold, and Supertin brands; vitamin C under the Vicee brand; supplement for kids with Zinc and vitamin C under the Imunped brand; Biogesic for various types of pain; Diatabs, a anti diarrhea product; and New Enzyplex to prevent indigestion. It also provides prescription products for various therapeutic areas, including cardiology, analgesics, gastro-hepatology, dermamedic, somatic, cough and cold, antibiotic, women healthcare, antiparasit, vitamin and food supplements, anti fungal, plastic surgery, general surgery, burn, trauma wound, aesthetic medicine, somatik, ear healthcare, and central nerve systems. In addition, the company offers toll manufacturing services for soft gelatin capsules, as well as sterile injections and low volume solid products. It also exports its products. The company was founded in 1976 and is headquartered in Jakarta, Indonesia. PT Darya-Varia Laboratoria Tbk operates as a subsidiary of Blue Sphere Singapore Pte. Ltd.

Address:

Tower C, Jakarta, Indonesia, 12430

People

Directors & Officers

Name Title Year Born
Dr. Ian Martin Wibawa Kloer President Director 1974
Mr. Celso Paz Lim Finance Director & Director 1969
Ms. Widya Olivia Tobing Head of Legal & Corporate Affairs Division and Corporate Secretary 1976
Mr. Dandan Darmawan Director of Human Resources Development NA
Mr. Chandra Ngesahkan Halomoan Tarigan Head of Internal Audit Unit 1979
Mr. Setyo Dumadi Treasury 1977

Financial Highlights

Market Cap: $1,786.40B
EBITDA: $246.78B
P/E Ratio: $13.07
Book Value: $1.34K
Dividend/Share: $64.00
Dividend Yield: 4.00%
Earnings/Share: $122.02
Profit Margin: 5.79%
Operating Margin: 8.16%
ROA (TTM): 4.34%
ROE (TTM): 9.10%
Revenue (TTM): $2,354.25B
Revenue/Share (TTM): $2.10K
Earnings Growth (YOY): -9.80%
Revenue Growth (YOY): 13.30%

Valuation Metrics

Enterprise Value: $1,321.10B
Trailing P/E: 13.07
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 1.12B
Shares Float: 88.27M
% Insiders: 92.12%
% Institutions: 0.012%

Stock Price History

1 Year Price History

3 Years Price History

10 Years Price History

Financial Charts

Revenue, Net Income & Operating Cash Flow (Yearly)

Revenue, Net Income & Operating Cash Flow (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$2,231.75B
Cost of Goods Sold
adjust
$-1,057.67B
Gross Profit
subtotal
$1,174.08B
SG&A
adjust
$-112.74B
Other Operating Expense
adjust
$-851.87B
Operating Income
subtotal
$209.48B
Other / Non-Operating Items
adjust
$-45.53B
Net Income
subtotal
$163.95B

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about DVLA.JK!